Search hospitals > Colorado > Lafayette
Good Samaritan Medical Center
Claim this profileLafayette, Colorado 80026
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lymphoma
76 reported clinical trials
6 medical researchers
Summary
Good Samaritan Medical Center is a medical facility located in Lafayette, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lymphoma and other specialties. Good Samaritan Medical Center is involved with conducting 76 clinical trials across 263 conditions. There are 6 research doctors associated with this hospital, such as Nicholas DiBella, Patrick Cobb, MD, Benjamin J. George, and Marwan Massouh.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder5 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
103 reported clinical trials
193 drugs studied
Patrick Cobb, MDSt. Vincent Frontier Cancer Center5 years of reported clinical research
Studies Breast Cancer
Studies Tumors
20 reported clinical trials
42 drugs studied
Benjamin J. GeorgeSCL Health Good Samaritan Medical Center Cancer Centers of Colorado5 years of reported clinical research
Studies Lymphoma
Studies Stomach Cancer
12 reported clinical trials
48 drugs studied
Marwan MassouhSaint James Community Hospital and Cancer Treatment Center6 years of reported clinical research
Studies Cancer
Studies Lung Cancer
11 reported clinical trials
35 drugs studied
Clinical Trials running at Good Samaritan Medical Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Ovarian Cancer
Fallopian Tube Cancer
Cancer
Lymphoma
Peritoneal Cancer
Mantle Cell Lymphoma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Good Samaritan Medical Center?
Good Samaritan Medical Center is a medical facility located in Lafayette, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lymphoma and other specialties. Good Samaritan Medical Center is involved with conducting 76 clinical trials across 263 conditions. There are 6 research doctors associated with this hospital, such as Nicholas DiBella, Patrick Cobb, MD, Benjamin J. George, and Marwan Massouh.